Patients with systemic sclerosis who report more severe reflux symptoms demonstrate worse interstitial lung disease outcomes despite receiving standard therapy, according to data published in Arthritis Care & Research.“Predicting which patients are likely to experience progressive pulmonary fibrosis is a challenge in systemic sclerosis,” Elizabeth R. Volkmann, MD, MS, director of the scleroderma program at the University of California Los Angeles, told Healio. “The motivation for this study was to understand whether the severity of esophageal involvement contributes toRead More
- (305) 687-1367
- info@flgastro.org
- Mon - Fri: 9:00am - 5:00pm